Partnership Marks Milestone in Additive Manufacturing for Orthopaedic Implants
Sweden-based Freemelt AB has secured a significant partnership with a leading global orthopaedic implant original equipment manufacturer (OEM). This collaboration centers around demonstrating the serial production capabilities of Freemelt’s eMELT Electron Beam Powder Bed Fusion (PBF-EB) Additive Manufacturing (AM) system. The deal, which expands Freemelt’s growing presence in the orthopaedic implant sector, will see the eMELT machine installed at the OEM’s production plant in Q2 2025 for a proof-of-concept project.
This partnership highlights Freemelt’s growing role in transforming the orthopaedic implant manufacturing process through advanced additive manufacturing technologies. Freemelt now has two established orthopaedic implant OEMs among its clientele, reinforcing its position as a key player in the field.
eMELT System: Revolutionizing Titanium Implant Production
The eMELT system, Freemelt’s industrial-grade machine, is uniquely suited for the production of titanium-based implants. Titanium’s high strength, biocompatibility, and durability make it an ideal material for orthopaedic implants. As the demand for additive-manufactured implants increases — expected to rise from $1.7 billion in 2023 to $6.6 billion by 2032 — the eMELT system offers an efficient, high-productivity solution tailored for the specific needs of implant manufacturing. The eMELT’s capabilities in producing titanium implants will be a critical component in meeting this market demand, which is driven by aging populations and the growing need for joint replacements.
Expertise and Support in Additive Manufacturing Process
In addition to providing the eMELT system, Freemelt will also contribute its extensive expertise in PBF-EB technology, offering process and application engineering support. This collaboration enables the OEM to leverage Freemelt’s advanced manufacturing capabilities to push the boundaries of orthopaedic implant production. With Freemelt’s technological assistance, the OEM is expected to achieve significant advancements in production efficiency and innovation within the orthopaedic implant market.
Leave a Reply
You must be logged in to post a comment.